Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 28, 2026 09:04 ET | Source: MiNK Therapeutics

MiNK Therapeutics Announces First Patient Dosed in Randomized Phase 2 Trial of agenT-797 in Acute Lung Injury and Critical Illness

First patient dosed marks rapid transition from trial activation to active treatment in patients with acute lung injury from all cause pneumonia meeting Global ARDS criteriaLandmark advances a...
May 27, 2026 07:30 ET | Source: Quantum Cyber

Quantum Cyber Files Provisional Patent Application for Coaxial Dual-Propellant Grain Solid Rocket Motor Designed to Extend Range and Loiter Time of Defense UAVs

WEST PALM BEACH, Florida, May 27, 2026 (GLOBE NEWSWIRE) -- Quantum Cyber N.V. (Nasdaq: QUCY) (“Quantum Cyber” or the “Company”), a Nasdaq-listed autonomous defense technology company assembling an...
May 26, 2026 08:02 ET | Source: Safe Pro Group Inc.

Safe Pro Celebrates 50,000th AI-Powered Landmine Detection Milestone Pioneering Modernized Force Protection and Humanitarian Innovation

Safe Pro Celebrates 50,000th AI-Powered Landmine Detection Milestone Pioneering Modernized Force Protection and Humanitarian Innovation
May 20, 2026 16:28 ET | Source: Church World Service

Congress Reviews Possible Changes to 2026 Refugee Admissions as Program Reaches Ceiling

Washington, D.C., May 20, 2026 (GLOBE NEWSWIRE) -- Ahead of Congressional consultations scheduled this week to adjust the 2026 refugee admissions ceiling, media reports suggest the Trump...
May 19, 2026 04:00 ET | Source: Amphiform

Amphiform Raises $5.5M Led by General Catalyst and Main Object to Solve Energy Bottlenecks for Data Centres, Space and Defence

Oxford-based deep tech startup is building atomically engineered fuel cells: 85% cheaper and 30x more power-dense, running on renewable liquid fuels.
May 14, 2026 07:30 ET | Source: MiNK Therapeutics

MiNK Therapeutics and First Lviv Territorial Medical Union Initiate Randomized Phase 2 Trial of agenT-797 in Acute Lung Injury and Critical Illness

Randomized Phase 2 trial evaluates off-the-shelf invariant natural killer T (iNKT) cell therapy in patients with acute lung injury and hypoxemic respiratory failure Study initiates in Lviv, Ukraine,...
May 09, 2026 16:31 ET | Source: ThinkCareBelieve

ThinkCareBelieve: Week 68 of the Trump 2.0 Administration

This week (Week 68) in the Trump Administration focused on honoring mothers, military families, and faith, highlighted by the National Day of Prayer.
April 20, 2026 07:00 ET | Source: SPARC AI INC

SPARC AI Signs Second Ukrainian Drone Manufacturer, Expanding Distribution Footprint for GPS-Denied Software Platform

SPARC AI signs second Ukrainian drone manufacturer to Overwatch platform, expanding distribution of its GPS-denied navigation and targeting software.
March 31, 2026 08:40 ET | Source: Maris-Tech Ltd.

Maris-Tech Expands into the Ukrainian Drone Video Payload Market

Initial deployment of AI-powered edge video solutions based on Maris-Tech’s field-proven Jupiter product line Rehovot, Israel, March 31, 2026 (GLOBE NEWSWIRE) -- Maris-Tech Ltd. (Nasdaq: MTEK,...
March 30, 2026 09:28 ET | Source: BiomX

BiomX Adds Former Mossad Deputy to Advisory Board

NETANYA, Israel, March 30, 2026 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE), today announced the appointment of Dr. Ehud (Udi) Levi to its newly formed Advisory Board. Dr. Levi will...